Allergic Immunologic

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC1-21

DiraChart Clinical Reference
Protected section 21 of 25
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 21 of 25PreviousNext

17. Common audit and denial risks

The patterns below are the system-specific failure modes; each maps to Segment 6 (Denial Patterns).

  • Reaction status charted qualitatively (“no reaction”) without an action-plan or auto-injector check.
  • An auto-injector charted as present without expiration or technique verification.
  • A reaction or a fever in immunosuppression noted without action or the correct urgency (no closed loop).
  • Repetitive, cloned allergic/immune notes with identical wording and no trajectory.
  • Teaching documented as “educated on allergies” without learner response or return demonstration.
  • A stable patient charted without an articulated ongoing skilled need (no readiness, surveillance, or teaching rationale).
Section NavigationPart 21 of 25PreviousNext